Next Article in Journal
Recent Advances in Photocatalytic Oxidation of Methane to Methanol
Next Article in Special Issue
Phenolic Profiles, Antioxidant and Anti-Inflammatory Activities of Hydrodistillation Wastewaters from Five Lamiaceae Species
Previous Article in Journal
Dwarf Kiwi (Actinidia arguta Miq.), a Source of Antioxidants for a Healthy and Sustainable Diet
Previous Article in Special Issue
Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chrysanthemum boreale Makino Inhibits Oxidative Stress-Induced Neuronal Damage in Human Neuroblastoma SH-SY5Y Cells by Suppressing MAPK-Regulated Apoptosis

1
Department of Convergence Medicine, Pusan National University School of Medicine, Yangsan 50612, Korea
2
Department of Life Science and Environmental Biochemistry, Life and Industry Convergence Research Institute, Pusan National University, Miryang 50463, Korea
3
New Drug Development Center, Daegu–Gyeongbuk Medical Innovation Foundation, K-MEDI Hub, Daegu 41061, Korea
4
Department of Biochemistry, Department of Convergence Medical Science, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea
*
Authors to whom correspondence should be addressed.
Submission received: 31 July 2022 / Revised: 23 August 2022 / Accepted: 24 August 2022 / Published: 26 August 2022
(This article belongs to the Special Issue Plants Extractions in Health Care)

Abstract

:
Oxidative stress has been demonstrated to play a pivotal role in the pathological processes of many neurodegenerative diseases. In the present study, we demonstrated that Chrysanthemum boreale Makino extract (CBME) suppresses oxidative stress-induced neurotoxicity in human neuroblastoma SH-SY5Y cells and elucidated the underlying molecular mechanism. Our observations revealed that CBME effectively protected neuronal cells against H2O2-induced cell death by preventing caspase-3 activation, Bax upregulation, Bcl-2 downregulation, activation of three mitogen-activated protein kinases (MAPKs), cAMP response element-binding protein (CREB) and NF-κB phosphorylation, and iNOS induction. These results provide evidence that CBME has remarkable neuroprotective properties in SH-SY5Y cells against oxidative damage, suggesting that the complementary or even alternative role of CBME in preventing and treating neurodegenerative diseases is worth further studies.

1. Introduction

Reactive oxygen species (ROS) are chemically reactive molecules normally produced in living organisms as a result of normal cellular metabolism [1]. ROS plays important roles in mediating cellular activities, such as immune responses, inflammation, cell survival, and stress responses. However, owing to their high reactivity, excess production of ROS can lead to harmful responses, including cell death or oxidative stress, which results from an imbalance in pro-oxidant/antioxidant homeostasis [2]. Among various ROS, H2O2 is one of the major agents produced by oxidative stress and acts as a precursor of ROS. H2O2 induces apoptosis in various cells, and neural cells exposed to H2O2 undergo necrosis and apoptosis [3,4]. Cumulative oxidative stress may induce cellular damage and mitochondrial dysfunction, which are major factors in aging and neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. Because of the high oxygen demand of the brain, it is susceptible to the effects of high levels of ROS, and protection from oxidative stress is crucial for the prevention and treatment of neurodegenerative disorders. Several recent studies have reported that inhibiting ROS generation and increasing cellular antioxidants may be beneficial for protecting against neurodegenerative diseases caused by oxidative stress [5]. Therefore, antioxidants are thought to be substances that may protect against brain disorders. Natural products such as polyphenols, flavonoids, carbohydrates, and their derivatives contain a large group of antioxidant compounds with reducing and radical scavenging properties [6].
Chrysanthemum boreale Makino, belonging to the Asteraceae family, is a small, yellow-flowered wild species widely distributed in East Asian countries including mainland China, South Korea, and Japan [7,8,9,10,11]. It is an important medicinal plant that contains various pharmacologically active components including polyacetylenes, essential oils, and flavonoids [12,13,14,15]. C. boreale has been reported to possess potential medicinal properties against bacterial action, inflammation, angiogenesis, and hypertension [16,17,18,19,20,21,22]. However, there is no scientific evidence of the neuroprotective properties of C. boreale. Therefore, in this study, we investigated the effect of C. boreale on oxidative stress-induced cell damage in human neuroblastoma SH-SY5Y cells.

2. Results

2.1. Chrysanthemum boreale Makino Extract Exhibited No Obvious Cytotoxic Effects in SH-SY5Y Cells

Initially, we examined the toxicity of C. boreale Makino extract (CBME) on SH-SY5Y human neuroblastoma cells. The cell viability assay showed that CBME did not exert any apparent cytotoxic and proliferative effects at concentrations of up to 200 µg/mL in SH-SY5Y cells under normal conditions (Figure 1A). Therefore, we used CBME concentrations of 50, 100, and 150 µg/mL to evaluate the effect of CBME against oxidative stress in a dose-dependent manner.
We treated SH-SY5Y cells with different concentrations of hydrogen peroxide (H2O2) for 24 h to determine the suitable concentration at which its effects on cytotoxic potency can be observed. The viability of SH-SY5Y cells decreased in a concentration-dependent manner. At a concentration of 50 µM, H2O2 resulted in ~50% cell mortality (Figure 1B). The cytotoxic potency of H2O2 at 50 µM concentration was confirmed at different incubation durations ranging from 6 to 48 h (Figure 1C). Thus, cells were treated with 50 µM H2O2 for 24 h for subsequent experiments.

2.2. Chrysanthemum boreale Makino Extract Inhibited Hydrogen Peroxide (H2O2)-Induced Neurotoxicity in SH-SY5Y Cells

To investigate the neuroprotective effects of CBME, we performed the following experiment using an oxidative stress model in which H2O2 was used to treat SH-SY5Y human neuroblastoma cells. As expected, we observed H2O2-induced alterations in cell morphology as reported previously (Figure 2A) [23,24]. The cells which were only treated with H2O2 underwent massive cell death, whereas the CBME pre-treated cells were resistant to cell death, which was confirmed both visually and by the WST-1 assay (Figure 2A,B).
H2O2, a well-known substance generated by oxidative stress, can evoke neuronal cell death by acting as a mediator of apoptosis [25,26,27,28,29]. Caspase-3, a member of the cysteine-aspartic acid protease (caspase) family, executes apoptosis and has been shown to be activated by H2O2 as a principal apoptosis-associated effector caspase [30,31,32,33]. Therefore, we evaluate caspase-3 activity by measuring the level of cleaved caspase-3 protein using Western blotting to confirm the protective effect of CBME on H2O2-induced oxidative stress. When the cells were treated with only H2O2, the level of cleaved caspase-3 was increased compared with that in vehicle-treated cells (Figure 2C, first and second lanes). However, the cells pre-treated with CBME showed a significant decrease in the level of cleaved caspase-3 in a CBME concentration-dependent manner against the H2O2-induced expression of cleaved caspase-3 (Figure 2C,D). These results showed that CBME protected SH-SY5Y cells against H2O2-induced cell damage.

2.3. Chrysanthemum boreale Makino Extract Inhibited H2O2-Stimulated Bax/Bcl-2 Pathway in SH-SY5Y Cells

As pathological apoptosis is induced by various apoptosis-associated genes [34], we further investigated the neuroprotective effect of CBME against H2O2-induced cell death by measuring the expression levels of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins [35]. In cells treated with H2O2 alone, the level of pro-apoptotic Bax protein was increased, whereas the level of anti-apoptotic Bcl-2 protein was decreased in comparison with that in vehicle-treated cells (Figure 3B, first and second lanes). However, pretreatment with CBME decreased H2O2-stimulated Bax expression and increased H2O2-reduced Bcl-2 expression in a dose-dependent manner (Figure 3B,C). These data confirmed that CBME effectively protected neuronal cells against H2O2-induced cell death.

2.4. Chrysanthemum boreale Makino Extract Suppressed H2O2-Induced Mitogen-Activated Protein Kinase (MAPK) Pathway

Numerous studies have demonstrated that H2O2-induced oxidative stress may trigger apoptosis by activating the MAPK family [36,37,38]. Therefore, we examined the involvement of the MAPK pathway in the mechanism underlying this action to understand the molecular mechanism underlying the suppression of H2O2-induced cell damage by CBME. The activation of ERK 1/2, JNK 1/2, and p38, which are members of the MAPK kinase family, was tested by measuring the level of phosphorylated proteins.
H2O2 treatment significantly increased the levels of phospho-ERK 1/2, phospho-JNK 1/2, and phospho-p38 MAPK proteins compared with vehicle (Figure 4A–C, first and second lanes). However, incubation with CBME decreased H2O2-induced phosphorylation of JNK 1/2, p38, and especially ERK 1/2 (Figure 4) in a dose-dependent manner. The total protein levels of the three MAPKs did not change in H2O2- and/or CBME-treated cells. These observations indicate that CBME protects neuronal cells against H2O2-induced oxidative stress by inhibiting the activation of MAPK signaling.

2.5. Chrysanthemum boreale Makino Extract Prevented H2O2-Induced Phosphorylation of CREB in SH-SY5Y Cells

CREB, a cAMP response element-binding protein, is an important transcription factor with various functions [39,40] and is known to play an essential role in neuronal survival [41,42] and long-term memory formation [43,44,45]. CREB activation occurs via phosphorylation of serine 133 by a number of protein kinases, including MAPKs [46,47]. To further explore the neuroprotective mechanism of CBME in SH-SY5Y cells, we investigated the phosphorylation of CREB protein using Western blotting analysis. We observed that CREB phosphorylation was enhanced by H2O2 treatment (Figure 5A, first and second lanes). However, the enhanced phosphorylation of CREB was suppressed by incubation with CBME at concentrations of 100 and 150 µg/mL (Figure 5A,B). These results suggest that CBME has the potential to inhibit H2O2-induced cell death by suppressing MAPK-regulated apoptosis.

2.6. Chrysanthemum boreale Makino Extract Attenuated H2O2-Induced NF-kB Phosphorylation and iNOS Induction

Next, we evaluated the protective molecular mechanisms of CBME by measuring inflammation-related protein expression. The NF-κB pathway is a pivotal pro-inflammatory mediator that plays a key role in oxidative stress [48,49,50]. Therefore, we examined the protein levels of NF-κB, phospho-NF-κB, and iNOS in H2O2-induced SH-SY5Y cells. After H2O2 exposure, the protein expression of phospho-NF-κB and iNOS was significantly upregulated compared with that in vehicle-treated cells (Figure 6A, first and second lanes). However, the increased phosphorylation of NF-κB was attenuated by incubation with CBME at concentrations of 100 and 150 µg/mL. Moreover, iNOS expression was suppressed by CBME in a dose-dependent manner (Figure 6A,B). The total protein levels of NF-κB did not change in H2O2-and/or CBME-treated cells. These results suggest that CBME protects SH-SY5Y cells against H2O2-induced oxidative stress by attenuating NF-κb-mediated inflammation.

3. Discussion

Oxidative stress has been demonstrated to play a pivotal role in the pathological processes of many neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis [51,52,53]. Natural products have less toxicity and fewer side effects as compared to chemical compounds. They can help in preventing and treating various neurodegenerative diseases. For this reason, numerous studies have attempted to investigate their neuroprotective properties which can be leveraged to inhibit neural damage caused by oxidative stress [54,55,56,57].
In the present study, we investigated the protective activity of CBME in human neuroblastoma SH-SY5Y cells from H2O2-induced apoptosis. Numerous studies have used SH-SY5Y cells as a cellular model for research on H2O2-induced neurotoxicity [58,59]. H2O2 is widely known as one of the major inducers of oxidative stress, resulting in neuronal cell death [60], and a link between neurodegenerative diseases and apoptosis and inflammation in the brain has also been reported [61,62]. Based on our results, we demonstrated that CBME pretreatment significantly attenuated neuronal cell injury caused by H2O2-induced oxidative stress (Figure 2A,B). Moreover, we confirmed the protective effects by measuring the level of cleaved caspase-3 protein (Figure 2C,D), a critical executor of apoptotic cell death that is activated by H2O2 [33,63].
The anti-apoptotic factor Bcl-2 and pro-apoptotic factor Bax are well characterized as being related to cell viability [64]. Moreover, H2O2-induced apoptosis has been shown to have a functional relationship with the anti- and pro-apoptotic regulatory factors Bcl-2 and Bax in neurons [65]. Overexpression of Bcl-2 heterodimerizes with Bax to repress apoptotic cell death. In contrast, Bax enhances apoptosis in response to a variety of death signals (such as, DNA damage, growth factor withdrawal, steroid hormones, or ligation of death receptors) [66,67]. Our data showed that CBME repressed Bax expression and enhanced Bcl-2 expression during H2O2-induced apoptosis (Figure 3). Thus, these results demonstrate the protective role of CBME in the regulation of Bcl-2- and Bax-dependent apoptotic pathways.
We also examined the possible association of the MAPK pathway to elucidate the molecular mechanisms underlying the suppression of H2O2-induced cell damage by CBME. We observed that the phosphorylation levels of JNK 1/2, p38, and ERK 1/2 were markedly increased in H2O2-treated cells as previously reported (Figure 4A–C, first and second lanes) [24,68,69,70,71]. Interestingly, CBME pretreatment significantly suppressed H2O2-induced phosphorylation of JNK 1/2, p38, and especially ERK 1/2 (Figure 4A,D). A feasible explanation is that CBME may be the most sensitive to trigger caspase-3 inactivation and ERK 1/2 inactivation, allowing a degree of neuroprotection against H2O2-induced cell damage. Reportedly, ERK phosphorylates CREB [72,73]. To further explore the neuroprotective mechanism of CBME in SH-SY5Y cells, we investigated the phosphorylation of CREB protein (Figure 5) because the phosphorylation of ERK was dramatically reduced by CBEM in the aforementioned results (Figure 4A,D). Moreover, we observed inflammation-related protein expression (Figure 6) because increased phosphorylation levels of JNK and p38 can further lead to inflammatory reactions [74,75,76,77]. Our results also showed that after H2O2 exposure, the phosphorylation of CREB and NF-κB, and iNOS expression was significantly elevated. Notably, these effects were reversed in a dose-dependent manner by CBME treatment. These results strongly support the hypothesis that CBME has the potential to suppress H2O2-induced cell death by attenuating MAPK-regulated apoptotic cell loss and NF-κB-mediated inflammation. The proposed neuroprotective mechanism of CBME is shown in Figure 7.
Taken together, we showed that CBME protected against neurotoxicity from H2O2-induced oxidative stress, and the protective mechanism was concomitant, at least partly, through the MAPK-mediated pathway, as well as caspase-3 inactivation. Our current findings provide the first evidence that CBME has remarkable neuroprotective properties in SH-SY5Y cells against oxidative damage and the various mechanisms involved. Although further studies are necessary to examine it’s in vivo functions and explain further details of the underlying mechanisms, this suggests that CBME may have a potential therapeutic effect on oxidative stress-related neurological disorders. In conclusion, the present study suggests that CBME should be studied further as a complementary or even an alternative role in preventing and treating neurodegenerative diseases.

4. Materials and Methods

4.1. Cell Culture

Human neuroblastoma SH-SY5Y cells were obtained from the Korean Cell Line Bank (Seoul, Korea) and cultured in Dulbecco’s modified Eagle’s medium (GIBCO, Waltham, MA, USA) supplemented with 10% heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA), penicillin (100 units/mL), and streptomycin sulfate (100 µg/mL). Cells were maintained at 37 °C in a humidified atmosphere containing 5% CO2. Cells were pretreated with various concentrations of CBME for 3 h and then washed twice with phosphate-buffered saline (PBS). Subsequently, these pre-treated cells were exposed to H2O2 (50 µM) for 24 h.

4.2. Preparation of Chrysanthemum boreale Makino Extract

The plant extract powder (code number: KPM032-046) used in this study was obtained from the Korea Plant Extract Bank at the Korea Research Institute of Bioscience and Biotechnology (Daejeon, Korea) [78]. Briefly, whole dried portions of C. boreale Makino were cut into small pieces and extracted with 99.9% methyl alcohol for 3 days. After extraction, the solutions were filtered, concentrated, and dried to obtain a powder. The extract powder was dissolved in dimethyl sulfoxide before use.

4.3. Cell Viability Assay

Cell viability after H2O2 or CBME treatment was measured using the water-soluble tetrazolium salt 1 (WST-1; EZ-CyTox, Dogen, Korea) assay. SH-SY5Y cells were seeded into 96-well plates at a density of 5 × 104 cells/well, and incubated in Dulbecco’s modified Eagle’s medium for 24 h. The cells were treated with the indicated concentration of either H2O2 or CBME for the indicated duration, and then cell viability was measured using the WST-1 assay according to the manufacturer’s instructions. After the WST-1 solution was added to each well (10% of the total volume), and the cells were incubated for 1 h, the absorbance was measured using a microplate reader at 450 nm. The optical density of the control cells was considered 100% viability.

4.4. Immunoblot Analysis

Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene fluoride membranes. After blocking with 3% BSA in TBS-T (137 mM NaCl, 20 mM Tris-Cl, pH 7.6, 0.1% Tween 20), the membranes were incubated with various primary antibodies, including anti-cleaved caspase-3 (cell signaling 9664), anti-Bax (cell signaling 2772), anti-Bcl-2 (cell Signaling 15071), anti-p44/42 mitogen-activated protein kinase (MAPK; Erk1/2) (R&D systems MAB1576), anti-phospho-p44/42 MAPK (Erk1/2) (cell signaling 4377), anti-p38 MAPK (cell signaling 8690), anti-phospho-p38 MAPK (cell signaling 4511), anti-JNK (cell signaling 9252), anti-phospho-JNK (cell signaling 4668), anti-CREB (cell signaling 9197), anti-phospho-CREB (cell signaling 9198), anti-NF-κB (cell signaling 8242), anti-phospho-NFkB (cell signaling 3033), anti-iNOS (cell signaling 13120), and anti-tubulin (Sigma-Aldrich T6199). The blots were then incubated with a secondary antibody [anti-rabbit horseradish peroxidase-conjugate or anti-mouse horseradish peroxidase conjugate (Santa Cruz Biotechnology)], and the protein bands were visualized using an enhanced chemiluminescence detection system (Bio-Rad).

4.5. Statistical Analysis

Significant differences between groups were determined using two-tailed unpaired Student’s t-tests, and multiple comparisons were performed using one-way or two-way repeated-measures ANOVA with Tukey’s post-tests. The analysis was performed using Origin 8.0 (OriginLab Corporation, Northampton, MA, USA). Data are expressed as the mean ± standard error of the mean (SEM) of at least three independent experiments. p values < 0.05 were considered statistically significant and are indicated in the figure legends.

Author Contributions

Conceptualization, W.K. and K.M.L.; validation, P.S., S.Y.C. and K.M.L.; formal analysis, P.S. and J.S.H.; investigation, P.S., S.Y.C. and K.M.L.; resources, H.-J.S., C.-O.H. and Y.-J.K.; data curation, P.S., J.S.H., H.C.P., K.K.K., W.K. and K.M.L.; writing—original draft preparation, W.K. and K.M.L.; writing—review and editing, P.S., J.S.H., W.K. and K.M.L.; supervision, W.K. and K.M.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a Junior Faculty Support Program of Pusan National University and a grant (2019R1C1C1007045) from the National Research Foundation of Korea awarded to K.M.L.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors acknowledge the resources and support of the Mosaic Core Lab facilities at the College of Natural Resources and Life Science, Pusan National University.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cenini, G.; Lloret, A.; Cascella, R. Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View. Oxid. Med. Cell Longev. 2019, 2019, 2105607. [Google Scholar] [CrossRef] [PubMed]
  2. Liu, Z.; Zhou, T.; Ziegler, A.C.; Dimitrion, P.; Zuo, L. Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications. Oxid. Med. Cell Longev. 2017, 2017, 2525967. [Google Scholar] [CrossRef] [PubMed]
  3. Ishikawa, Y.; Satoh, T.; Enokido, Y.; Nishio, C.; Ikeuchi, T.; Hatanaka, H. Generation of reactive oxygen species, release of L-glutamate and activation of caspases are required for oxygen-induced apoptosis of embryonic hippocampal neurons in culture. Brain Res. 1999, 824, 71–80. [Google Scholar] [CrossRef]
  4. Sherer, T.B.; Betarbet, R.; Stout, A.K.; Lund, S.; Baptista, M.; Panov, A.V.; Cookson, M.R.; Greenamyre, J.T. An in vitro model of Parkinson’s disease: Linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. 2002, 22, 7006–7015. [Google Scholar] [CrossRef]
  5. Menon, D.K.; Peden, C.J.; Hall, A.S.; Sargentoni, J.; Whitwam, J.G. Magnetic resonance for the anaesthetist. Part I: Physical principles, applications, safety aspects. Anaesthesia 1992, 47, 240–255. [Google Scholar] [CrossRef] [PubMed]
  6. Kim, M.R. Antioxidants of Natural Products. Antioxidants 2021, 10, 612. [Google Scholar] [CrossRef]
  7. Pyee, Y.; Chung, H.J.; Choi, T.J.; Park, H.J.; Hong, J.Y.; Kim, J.S.; Kang, S.S.; Lee, S.K. Suppression of inflammatory responses by handelin, a guaianolide dimer from Chrysanthemum boreale, via downregulation of NF-kappaB signaling and pro-inflammatory cytokine production. J. Nat. Prod. 2014, 77, 917–924. [Google Scholar] [CrossRef]
  8. Kim, B.S.; Park, S.J.; Kim, M.K.; Kim, Y.H.; Lee, S.B.; Lee, K.H.; Choi, N.Y.; Lee, Y.R.; Lee, Y.E.; You, Y.O. Inhibitory Effects of Chrysanthemum boreale Essential Oil on Biofilm Formation and Virulence Factor Expression of Streptococcus mutans. Evid. Based Complement Alternat. Med. 2015, 2015, 616309. [Google Scholar] [CrossRef]
  9. Ryu, Y.; Lee, D.; Jung, S.H.; Lee, K.J.; Jin, H.; Kim, S.J.; Lee, H.M.; Kim, B.; Won, K.J. Sabinene Prevents Skeletal Muscle Atrophy by Inhibiting the MAPK-MuRF-1 Pathway in Rats. Int. J. Mol. Sci. 2019, 20, 4955. [Google Scholar] [CrossRef]
  10. Won, S.Y.; Jung, J.A.; Kim, J.S. The complete chloroplast genome of Chrysanthemum boreale (Asteraceae). Mitochondrial DNA B Resour. 2018, 3, 549–550. [Google Scholar] [CrossRef]
  11. Won, S.Y.; Jung, J.A.; Kim, J.S. The complete mitochondrial genome sequence of Chrysanthemum boreale (Asteraceae). Mitochondrial DNA B Resour. 2018, 3, 529–530. [Google Scholar] [CrossRef] [PubMed]
  12. Lee, J.R.; Yang, M.S.; Lee, J.; Hwang, S.W.; Kho, Y.H.; Park, K.H. New guaianolides from leaves and stems of Chrysanthemum boreale. Planta Med. 2003, 69, 880–882. [Google Scholar] [CrossRef] [PubMed]
  13. Nugroho, A.; Lim, S.C.; Choi, J.; Park, H.J. Identification and quantification of the sedative and anticonvulsant flavone glycoside from Chrysanthemum boreale. Arch Pharm. Res. 2013, 36, 51–60. [Google Scholar] [CrossRef]
  14. Kim, D.Y.; Won, K.J.; Yoon, M.S.; Yu, H.J.; Park, J.H.; Kim, B.; Lee, H.M. Chrysanthemum boreale flower floral water inhibits platelet-derived growth factor-stimulated migration and proliferation in vascular smooth muscle cells. Pharm. Biol. 2015, 53, 725–734. [Google Scholar] [CrossRef] [PubMed]
  15. Kim, D.Y.; Won, K.J.; Hwang, D.I.; Park, S.M.; Kim, B.; Lee, H.M. Chemical Composition, Antioxidant and Anti-melanogenic Activities of Essential Oils from Chrysanthemum boreale Makino at Different Harvesting Stages. Chem. Biodivers. 2018, 15, e1700506. [Google Scholar] [CrossRef]
  16. Hu, C.Q.; Chen, K.; Shi, Q.; Kilkuskie, R.E.; Cheng, Y.C.; Lee, K.H. Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids. J. Nat. Prod. 1994, 57, 42–51. [Google Scholar] [CrossRef]
  17. Kim, K.J.; Kim, Y.H.; Yu, H.H.; Jeong, S.I.; Cha, J.D.; Kil, B.S.; You, Y.O. Antibacterial activity and chemical composition of essential oil of Chrysanthemum boreale. Planta Med. 2003, 69, 274–277. [Google Scholar] [CrossRef]
  18. Cheon, M.S.; Yoon, T.; Lee, D.Y.; Choi, G.; Moon, B.C.; Lee, A.Y.; Choo, B.K.; Kim, H.K. Chrysanthemum indicum Linne extract inhibits the inflammatory response by suppressing NF-kappaB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophages. J. Ethnopharmacol. 2009, 122, 473–477. [Google Scholar] [CrossRef]
  19. Lee, D.Y.; Choi, G.; Yoon, T.; Cheon, M.S.; Choo, B.K.; Kim, H.K. Anti-inflammatory activity of Chrysanthemum indicum extract in acute and chronic cutaneous inflammation. J. Ethnopharmacol. 2009, 123, 149–154. [Google Scholar] [CrossRef]
  20. Kim, Y.; Sung, J.; Sung, M.; Choi, Y.; Jeong, H.S.; Lee, J. Involvement of heme oxygenase-1 in the anti-inflammatory activity of Chrysanthemum boreale Makino extracts on the expression of inducible nitric oxide synthase in RAW264.7 macrophages. J. Ethnopharmacol. 2010, 131, 550–554. [Google Scholar] [CrossRef]
  21. Kim, D.Y.; Won, K.J.; Yoon, M.S.; Hwang, D.I.; Yoon, S.W.; Park, J.H.; Kim, B.; Lee, H.M. Chrysanthemum boreale Makino essential oil induces keratinocyte proliferation and skin regeneration. Nat. Prod. Res. 2015, 29, 562–564. [Google Scholar] [CrossRef] [PubMed]
  22. Chung, K.S.; Hong, J.Y.; Lee, J.H.; Lee, H.J.; Park, J.Y.; Choi, J.H.; Park, H.J.; Hong, J.; Lee, K.T. beta-Caryophyllene in the Essential Oil from Chrysanthemum Boreale Induces G1 Phase Cell Cycle Arrest in Human Lung Cancer Cells. Molecules 2019, 24, 3754. [Google Scholar] [CrossRef] [PubMed]
  23. Gardner, A.M.; Xu, F.H.; Fady, C.; Jacoby, F.J.; Duffey, D.C.; Tu, Y.; Lichtenstein, A. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic. Biol. Med. 1997, 22, 73–83. [Google Scholar] [CrossRef]
  24. Lee, K.M.; Lee, A.S.; Choi, I. Melandrii Herba Extract Attenuates H(2)O(2)-Induced Neurotoxicity in Human Neuroblastoma SH-SY5Y Cells and Scopolamine-Induced Memory Impairment in Mice. Molecules 2017, 22, 1646. [Google Scholar] [CrossRef] [PubMed]
  25. Jiang, D.; Jha, N.; Boonplueang, R.; Andersen, J.K. Caspase 3 inhibition attenuates hydrogen peroxide-induced DNA fragmentation but not cell death in neuronal PC12 cells. J. Neurochem. 2001, 76, 1745–1755. [Google Scholar] [CrossRef]
  26. Slater, A.F.; Nobel, C.S.; Orrenius, S. The role of intracellular oxidants in apoptosis. Biochim. Biophys. Acta 1995, 1271, 59–62. [Google Scholar] [CrossRef]
  27. Jacobson, M.D. Reactive oxygen species and programmed cell death. Trends. Biochem. Sci. 1996, 21, 83–86. [Google Scholar] [CrossRef]
  28. McGowan, A.J.; Fernandes, R.S.; Samali, A.; Cotter, T.G. Anti-oxidants and apoptosis. Biochem. Soc. Trans. 1996, 24, 229–233. [Google Scholar] [CrossRef]
  29. Slater, A.F.; Stefan, C.; Nobel, I.; van den Dobbelsteen, D.J.; Orrenius, S. Intracellular redox changes during apoptosis. Cell Death Differ. 1996, 3, 57–62. [Google Scholar]
  30. Alnemri, E.S.; Livingston, D.J.; Nicholson, D.W.; Salvesen, G.; Thornberry, N.A.; Wong, W.W.; Yuan, J. Human ICE/CED-3 protease nomenclature. Cell 1996, 87, 171. [Google Scholar] [CrossRef]
  31. Jeon, B.S.; Kholodilov, N.G.; Oo, T.F.; Kim, S.Y.; Tomaselli, K.J.; Srinivasan, A.; Stefanis, L.; Burke, R.E. Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J. Neurochem. 1999, 73, 322–333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Hartmann, A.; Hunot, S.; Michel, P.P.; Muriel, M.P.; Vyas, S.; Faucheux, B.A.; Mouatt-Prigent, A.; Turmel, H.; Srinivasan, A.; Ruberg, M.; et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson’s disease. Proc. Natl. Acad. Sci. USA 2000, 97, 2875–2880. [Google Scholar] [CrossRef]
  33. Matsura, T.; Kai, M.; Fujii, Y.; Ito, H.; Yamada, K. Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation. Free Radic. Res. 1999, 30, 73–83. [Google Scholar] [CrossRef] [PubMed]
  34. Mollazadeh, S.; Fazly Bazzaz, B.S.; Kerachian, M.A. Role of apoptosis in pathogenesis and treatment of bone-related diseases. J. Orthop. Surg. Res. 2015, 10, 15. [Google Scholar] [CrossRef]
  35. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007, 35, 495–516. [Google Scholar] [CrossRef] [PubMed]
  36. Guyton, K.Z.; Liu, Y.; Gorospe, M.; Xu, Q.; Holbrook, N.J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem. 1996, 271, 4138–4142. [Google Scholar] [CrossRef]
  37. Ferrer, I.; Blanco, R.; Carmona, M.; Puig, B.; Barrachina, M.; Gomez, C.; Ambrosio, S. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson’s disease and Dementia with Lewy bodies. J. Neural. Transm. (Vienna) 2001, 108, 1383–1396. [Google Scholar] [CrossRef]
  38. Nakano, H.; Nakajima, A.; Sakon-Komazawa, S.; Piao, J.H.; Xue, X.; Okumura, K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ. 2006, 13, 730–737. [Google Scholar] [CrossRef]
  39. Meyer, T.E.; Habener, J.F. Cyclic adenosine 3’,5’-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr. Rev. 1993, 14, 269–290. [Google Scholar] [CrossRef]
  40. Montminy, M.R.; Gonzalez, G.A.; Yamamoto, K.K. Regulation of cAMP-inducible genes by CREB. Trends. Neurosci. 1990, 13, 184–188. [Google Scholar] [CrossRef]
  41. Walton, M.R.; Dragunow, I. Is CREB a key to neuronal survival? Trends. Neurosci. 2000, 23, 48–53. [Google Scholar] [CrossRef]
  42. Yamada, M.; Tanabe, K.; Wada, K.; Shimoke, K.; Ishikawa, Y.; Ikeuchi, T.; Koizumi, S.; Hatanaka, H. Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons. J. Neurochem. 2001, 78, 940–951. [Google Scholar] [CrossRef] [PubMed]
  43. Bourtchuladze, R.; Frenguelli, B.; Blendy, J.; Cioffi, D.; Schutz, G.; Silva, A.J. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994, 79, 59–68. [Google Scholar] [CrossRef]
  44. Guzowski, J.F.; McGaugh, J.L. Antisense oligodeoxynucleotide-mediated disruption of hippocampal cAMP response element binding protein levels impairs consolidation of memory for water maze training. Proc. Natl. Acad. Sci. USA 1997, 94, 2693–2698. [Google Scholar] [CrossRef]
  45. Yin, J.C.; Tully, T. CREB and the formation of long-term memory. Curr. Opin. Neurobiol. 1996, 6, 264–268. [Google Scholar] [CrossRef]
  46. Shaywitz, A.J.; Greenberg, M.E. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 1999, 68, 821–861. [Google Scholar] [CrossRef]
  47. Mayr, B.; Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2001, 2, 599–609. [Google Scholar] [CrossRef]
  48. Hayden, M.S.; Ghosh, S. Shared principles in NF-kappaB signaling. Cell 2008, 132, 344–362. [Google Scholar] [CrossRef]
  49. Amor, S.; Puentes, F.; Baker, D.; van der Valk, P. Inflammation in neurodegenerative diseases. Immunology 2010, 129, 154–169. [Google Scholar] [CrossRef]
  50. Tilstra, J.S.; Clauson, C.L.; Niedernhofer, L.J.; Robbins, P.D. NF-kappaB in Aging and Disease. Aging Dis. 2011, 2, 449–465. [Google Scholar]
  51. Choi, J.; Sullards, M.C.; Olzmann, J.A.; Rees, H.D.; Weintraub, S.T.; Bostwick, D.E.; Gearing, M.; Levey, A.I.; Chin, L.S.; Li, L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 2006, 281, 10816–10824. [Google Scholar] [CrossRef] [PubMed]
  52. Stoy, N.; Mackay, G.M.; Forrest, C.M.; Christofides, J.; Egerton, M.; Stone, T.W.; Darlington, L.G. Tryptophan metabolism and oxidative stress in patients with Huntington’s disease. J. Neurochem. 2005, 93, 611–623. [Google Scholar] [CrossRef]
  53. Bellingham, M.C. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: What have we learned in the last decade? CNS Neurosci. Ther. 2011, 17, 4–31. [Google Scholar] [CrossRef] [PubMed]
  54. Koo, B.S.; Lee, W.C.; Chung, K.H.; Ko, J.H.; Kim, C.H. A water extract of Curcuma longa L. (Zingiberaceae) rescues PC12 cell death caused by pyrogallol or hypoxia/reoxygenation and attenuates hydrogen peroxide induced injury in PC12 cells. Life Sci. 2004, 75, 2363–2375. [Google Scholar] [CrossRef]
  55. Mandel, S.A.; Amit, T.; Weinreb, O.; Reznichenko, L.; Youdim, M.B. Simultaneous manipulation of multiple brain targets by green tea catechins: A potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci. Ther. 2008, 14, 352–365. [Google Scholar] [CrossRef]
  56. Shi, C.; Liu, J.; Wu, F.; Yew, D.T. Ginkgo biloba extract in Alzheimer’s disease: From action mechanisms to medical practice. Int. J. Mol. Sci. 2010, 11, 107–123. [Google Scholar] [CrossRef] [PubMed]
  57. Pandareesh, M.D.; Mythri, R.B.; Srinivas Bharath, M.M. Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases. Neurochem. Int. 2015, 89, 198–208. [Google Scholar] [CrossRef]
  58. Nirmaladevi, D.; Venkataramana, M.; Chandranayaka, S.; Ramesha, A.; Jameel, N.M.; Srinivas, C. Neuroprotective effects of bikaverin on H2O2-induced oxidative stress mediated neuronal damage in SH-SY5Y cell line. Cell Mol. Neurobiol. 2014, 34, 973–985. [Google Scholar] [CrossRef]
  59. Shin, K.Y.; Lee, G.H.; Park, C.H.; Kim, H.J.; Park, S.H.; Kim, S.; Kim, H.S.; Lee, K.S.; Won, B.Y.; Lee, H.G.; et al. A novel compound, maltolyl p-coumarate, attenuates cognitive deficits and shows neuroprotective effects in vitro and in vivo dementia models. J. Neurosci. Res. 2007, 85, 2500–2511. [Google Scholar] [CrossRef]
  60. Tabner, B.J.; Turnbull, S.; El-Agnaf, O.; Allsop, D. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. Curr. Top. Med. Chem. 2001, 1, 507–517. [Google Scholar] [CrossRef]
  61. Finkel, T.; Holbrook, N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408, 239–247. [Google Scholar] [CrossRef] [PubMed]
  62. Li, J.; Li, W.; Su, J.; Liu, W.; Altura, B.T.; Altura, B.M. Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: Possible relation to neurodegenerative diseases and strokes. Brain. Res. Bull. 2003, 62, 101–106. [Google Scholar] [CrossRef] [PubMed]
  63. Yamakawa, H.; Ito, Y.; Naganawa, T.; Banno, Y.; Nakashima, S.; Yoshimura, S.; Sawada, M.; Nishimura, Y.; Nozawa, Y.; Sakai, N. Activation of caspase-9 and -3 during H2O2-induced apoptosis of PC12 cells independent of ceramide formation. Neurol. Res. 2000, 22, 556–564. [Google Scholar] [CrossRef] [PubMed]
  64. Kale, J.; Osterlund, E.J.; Andrews, D.W. BCL-2 family proteins: Changing partners in the dance towards death. Cell Death Differ. 2018, 25, 65–80. [Google Scholar] [CrossRef] [PubMed]
  65. Jang, J.H.; Surh, Y.J. Possible role of NF-kappaB in Bcl-X(L) protection against hydrogen peroxide-induced PC12 cell death. Redox. Rep. 2004, 9, 343–348. [Google Scholar] [CrossRef]
  66. Korsmeyer, S.J. BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 1999, 59, 1693s–1700s. [Google Scholar] [CrossRef]
  67. Reed, J.C. Bcl-2 family proteins. Oncogene 1998, 17, 3225–3236. [Google Scholar] [CrossRef]
  68. Ruffels, J.; Griffin, M.; Dickenson, J.M. Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: Role of ERK1/2 in H2O2-induced cell death. Eur. J. Pharmacol 2004, 483, 163–173. [Google Scholar] [CrossRef]
  69. Spicer, Z.; Millhorn, D.E. Oxygen sensing in neuroendocrine cells and other cell types: Pheochromocytoma (PC12) cells as an experimental model. Endocr. Pathol. 2003, 14, 277–291. [Google Scholar] [CrossRef]
  70. Suzaki, Y.; Yoshizumi, M.; Kagami, S.; Koyama, A.H.; Taketani, Y.; Houchi, H.; Tsuchiya, K.; Takeda, E.; Tamaki, T. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: Potential role in cell survival following oxidative insults. J. Biol. Chem. 2002, 277, 9614–9621. [Google Scholar] [CrossRef]
  71. Pan, L.L.; Liu, X.H.; Jia, Y.L.; Wu, D.; Xiong, Q.H.; Gong, Q.H.; Wang, Y.; Zhu, Y.Z. A novel compound derived from danshensu inhibits apoptosis via upregulation of heme oxygenase-1 expression in SH-SY5Y cells. Biochim. Biophys. Acta 2013, 1830, 2861–2871. [Google Scholar] [CrossRef] [PubMed]
  72. Bonni, A.; Brunet, A.; West, A.E.; Datta, S.R.; Takasu, M.A.; Greenberg, M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286, 1358–1362. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Xing, J.; Ginty, D.D.; Greenberg, M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996, 273, 959–963. [Google Scholar] [CrossRef] [PubMed]
  74. Yang, Y.; Kim, S.C.; Yu, T.; Yi, Y.S.; Rhee, M.H.; Sung, G.H.; Yoo, B.C.; Cho, J.Y. Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses. Mediat. Inflamm. 2014, 2014, 352371. [Google Scholar] [CrossRef]
  75. Liu, J.; Lin, A. Role of JNK activation in apoptosis: A double-edged sword. Cell Res. 2005, 15, 36–42. [Google Scholar] [CrossRef]
  76. Kyriakis, J.M.; Avruch, J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81, 807–869. [Google Scholar] [CrossRef]
  77. Pua, L.J.W.; Mai, C.W.; Chung, F.F.; Khoo, A.S.; Leong, C.O.; Lim, W.M.; Hii, L.W. Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma. Int. J. Mol. Sci. 2022, 23, 1108. [Google Scholar] [CrossRef] [PubMed]
  78. Korea Plant Extract Bank. Available online: https://portal.kribb.re.kr/kpeb (accessed on 19 October 2020).
Figure 1. Effect of C. boreale Makino extract (CBME) and hydrogen peroxide (H2O2) on cell viability in SH-SY5Y cells. (A) The cells were exposed to the indicated doses of CBME for 24 h. Cell viability was evaluated using a WST-1 assay. (B) The cells were exposed to the indicated concentrations of H2O2 for 24 h. Cell viability was evaluated using the WST-1 assay. (C) The cells were incubated with 50 µM H2O2 for the indicated durations. Cell viability was evaluated using the WST-1 assay. The results are representative of four independent experiments. All data are presented as the mean ± SEM. # p < 0.05, ### p < 0.005, significantly different from the control group.
Figure 1. Effect of C. boreale Makino extract (CBME) and hydrogen peroxide (H2O2) on cell viability in SH-SY5Y cells. (A) The cells were exposed to the indicated doses of CBME for 24 h. Cell viability was evaluated using a WST-1 assay. (B) The cells were exposed to the indicated concentrations of H2O2 for 24 h. Cell viability was evaluated using the WST-1 assay. (C) The cells were incubated with 50 µM H2O2 for the indicated durations. Cell viability was evaluated using the WST-1 assay. The results are representative of four independent experiments. All data are presented as the mean ± SEM. # p < 0.05, ### p < 0.005, significantly different from the control group.
Molecules 27 05498 g001
Figure 2. Effects of Chrysanthemum boreale Makino extract (CBME) on H2O2-induced neural damage in SH-SY5Y cells. (A) Microscopic image of SH-SY5Y cells with or without 3 h pretreatment with CBME (150 µg/mL) and subsequently exposed to 50 µM H2O2 for an additional 24 h. The representative image was obtained by phase-contrast microscopy. Scale bar = 100 µm. (B) Cell viability was evaluated using the WST-1 assay in the same conditions as (A). (C) Western blot bands corresponding to cleaved caspase-3 in SH-SY5Y cells which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h (* denotes non-specific band). Tubulin was used as the loading control. (D) Relative band intensity of cleaved caspase-3 was quantified using densitometric analysis and then normalized to that of tubulin. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Figure 2. Effects of Chrysanthemum boreale Makino extract (CBME) on H2O2-induced neural damage in SH-SY5Y cells. (A) Microscopic image of SH-SY5Y cells with or without 3 h pretreatment with CBME (150 µg/mL) and subsequently exposed to 50 µM H2O2 for an additional 24 h. The representative image was obtained by phase-contrast microscopy. Scale bar = 100 µm. (B) Cell viability was evaluated using the WST-1 assay in the same conditions as (A). (C) Western blot bands corresponding to cleaved caspase-3 in SH-SY5Y cells which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h (* denotes non-specific band). Tubulin was used as the loading control. (D) Relative band intensity of cleaved caspase-3 was quantified using densitometric analysis and then normalized to that of tubulin. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Molecules 27 05498 g002
Figure 3. Effects of Chrysanthemum boreale Makino extract (CBME) on Bax and Bcl-2 expression in SH-SY5Y cells exposed to hydrogen peroxide. (A) Western blot bands corresponding to Bax and Bcl-2 in SH-SY5Y cells which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h. Tubulin was used as the loading control. (B) Relative band intensity of Bax were quantified using densitometric analysis and then normalized to tubulin. (C) Relative band intensity of Bcl-2 was quantified using densitometric analysis and then normalized to that of tubulin. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Figure 3. Effects of Chrysanthemum boreale Makino extract (CBME) on Bax and Bcl-2 expression in SH-SY5Y cells exposed to hydrogen peroxide. (A) Western blot bands corresponding to Bax and Bcl-2 in SH-SY5Y cells which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h. Tubulin was used as the loading control. (B) Relative band intensity of Bax were quantified using densitometric analysis and then normalized to tubulin. (C) Relative band intensity of Bcl-2 was quantified using densitometric analysis and then normalized to that of tubulin. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Molecules 27 05498 g003
Figure 4. Effects of Chrysanthemum boreale Makino extract (CBME) on the MAPK pathway in SH-SY5Y cells exposed to H2O2. (A) Western blot bands corresponding to ERK 1/2 and P-ERK 1/2 in SH-SY5Y cells, which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h. Tubulin was used as the loading control. (B) Western blot bands corresponding to JNK 1/2 and P-JNK ½. (C) Western blot bands corresponding to p38 and P-p38. (D) Relative band intensity of P-ERK 1/2 was quantified using densitometric analysis and then normalized to that of ERK 1/2. (E) Relative band intensity of P-JNK 1/2 was quantified using densitometric analysis and then normalized to that of JNK 1/2. (F) Relative band intensity of P-p38 was quantified using densitometric analysis and then normalized to that of p38. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, * p < 0.05, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Figure 4. Effects of Chrysanthemum boreale Makino extract (CBME) on the MAPK pathway in SH-SY5Y cells exposed to H2O2. (A) Western blot bands corresponding to ERK 1/2 and P-ERK 1/2 in SH-SY5Y cells, which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h. Tubulin was used as the loading control. (B) Western blot bands corresponding to JNK 1/2 and P-JNK ½. (C) Western blot bands corresponding to p38 and P-p38. (D) Relative band intensity of P-ERK 1/2 was quantified using densitometric analysis and then normalized to that of ERK 1/2. (E) Relative band intensity of P-JNK 1/2 was quantified using densitometric analysis and then normalized to that of JNK 1/2. (F) Relative band intensity of P-p38 was quantified using densitometric analysis and then normalized to that of p38. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, * p < 0.05, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Molecules 27 05498 g004
Figure 5. Effects of Chrysanthemum boreale Makino extract (CBME) on CREB phosphorylation in SH-SY5Y cells exposed to H2O2. (A) Western blot bands corresponding to CREB and P-CREB in SH-SY5Y cells, which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h. Tubulin was used as the loading control. (B) Relative band intensity of P-CREB was quantified using densitometric analysis and then normalized to that of CREB. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, * p < 0.05, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Figure 5. Effects of Chrysanthemum boreale Makino extract (CBME) on CREB phosphorylation in SH-SY5Y cells exposed to H2O2. (A) Western blot bands corresponding to CREB and P-CREB in SH-SY5Y cells, which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h. Tubulin was used as the loading control. (B) Relative band intensity of P-CREB was quantified using densitometric analysis and then normalized to that of CREB. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, * p < 0.05, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Molecules 27 05498 g005
Figure 6. Effects of Chrysanthemum boreale Makino extract (CBME) on NF-κB phosphorylation and iNOS in SH-SY5Y cells exposed to H2O2. (A) Western blot bands corresponding to NF-κB, P- NF-κB, and iNOS in SH-SY5Y cells, which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h. Tubulin was used as the loading control. (B) Relative band intensity of P-NF-κB was quantified using densitometric analysis and then normalized to that of NF-κB. (C) Relative band intensity of iNOS was quantified using densitometric analysis and then normalized to that of tubulin. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, ** p < 0.01, * p < 0.05, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Figure 6. Effects of Chrysanthemum boreale Makino extract (CBME) on NF-κB phosphorylation and iNOS in SH-SY5Y cells exposed to H2O2. (A) Western blot bands corresponding to NF-κB, P- NF-κB, and iNOS in SH-SY5Y cells, which were pre-treated with the indicated concentrations of CBME for 3 h and then exposed to H2O2 for 24 h. Tubulin was used as the loading control. (B) Relative band intensity of P-NF-κB was quantified using densitometric analysis and then normalized to that of NF-κB. (C) Relative band intensity of iNOS was quantified using densitometric analysis and then normalized to that of tubulin. Values in the bar graphs are the mean ± SEM of at least three independent experiments. *** p < 0.005, ** p < 0.01, * p < 0.05, significantly different from the H2O2 group. ### p < 0.005, significantly different from the control group.
Molecules 27 05498 g006
Figure 7. A schematic diagram illustrating the proposed protective mechanism of CBME against oxidative stress. CBME protects neuronal cells against H2O2-induced cell death by preventing caspase-3 activation, Bax upregulation, Bcl-2 downregulation, MAPK-regulated apoptotic cell loss, and NF-κB-mediated inflammation.
Figure 7. A schematic diagram illustrating the proposed protective mechanism of CBME against oxidative stress. CBME protects neuronal cells against H2O2-induced cell death by preventing caspase-3 activation, Bax upregulation, Bcl-2 downregulation, MAPK-regulated apoptotic cell loss, and NF-κB-mediated inflammation.
Molecules 27 05498 g007
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Song, P.; Choi, S.Y.; Hwang, J.S.; Park, H.C.; Kim, K.K.; Son, H.-J.; Hong, C.-O.; Kim, Y.-J.; Kim, W.; Lee, K.M. Chrysanthemum boreale Makino Inhibits Oxidative Stress-Induced Neuronal Damage in Human Neuroblastoma SH-SY5Y Cells by Suppressing MAPK-Regulated Apoptosis. Molecules 2022, 27, 5498. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules27175498

AMA Style

Song P, Choi SY, Hwang JS, Park HC, Kim KK, Son H-J, Hong C-O, Kim Y-J, Kim W, Lee KM. Chrysanthemum boreale Makino Inhibits Oxidative Stress-Induced Neuronal Damage in Human Neuroblastoma SH-SY5Y Cells by Suppressing MAPK-Regulated Apoptosis. Molecules. 2022; 27(17):5498. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules27175498

Chicago/Turabian Style

Song, Parkyong, Seo Young Choi, Ji Sun Hwang, Hyeon Cheal Park, Keun Ki Kim, Hong-Joo Son, Chang-Oh Hong, Yu-Jin Kim, Wanil Kim, and Kwang Min Lee. 2022. "Chrysanthemum boreale Makino Inhibits Oxidative Stress-Induced Neuronal Damage in Human Neuroblastoma SH-SY5Y Cells by Suppressing MAPK-Regulated Apoptosis" Molecules 27, no. 17: 5498. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules27175498

Article Metrics

Back to TopTop